##gff-version 3
##sequence-region Q9C0E8 1 428
Q9C0E8	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20213681,ECO:0000269|PubMed:24223779;Dbxref=PMID:20213681,PMID:24223779	
Q9C0E8	UniProtKB	Chain	2	428	.	.	.	ID=PRO_0000248310;Note=Endoplasmic reticulum junction formation protein lunapark	
Q9C0E8	UniProtKB	Topological domain	2	45	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24223779;Dbxref=PMID:24223779	
Q9C0E8	UniProtKB	Transmembrane	46	66	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9C0E8	UniProtKB	Topological domain	67	77	.	.	.	Note=Lumenal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24223779;Dbxref=PMID:24223779	
Q9C0E8	UniProtKB	Transmembrane	78	98	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9C0E8	UniProtKB	Topological domain	99	428	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24223779,ECO:0000269|PubMed:25548161;Dbxref=PMID:24223779,PMID:25548161	
Q9C0E8	UniProtKB	Zinc finger	276	301	.	.	.	Note=C4-type%3B plays a role in ER morphology;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24223779,ECO:0000269|PubMed:27619977;Dbxref=PMID:24223779,PMID:27619977	
Q9C0E8	UniProtKB	Coiled coil	16	41	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9C0E8	UniProtKB	Coiled coil	102	128	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9C0E8	UniProtKB	Compositional bias	178	250	.	.	.	Note=Pro-rich	
Q9C0E8	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	153	153	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	177	177	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:27619977;Dbxref=PMID:20068231,PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:27619977;Dbxref=PMID:18691976,PMID:20068231,PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	194	194	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:27619977;Dbxref=PMID:18691976,PMID:20068231,PMID:23186163,PMID:24275569,PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	211	211	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	213	213	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9C0E8	UniProtKB	Modified residue	217	217	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:27619977;Dbxref=PMID:23186163,PMID:24275569,PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	227	227	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18691976,ECO:0000269|PubMed:27619977;Dbxref=PMID:18691976,PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	353	353	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	384	384	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:27619977;Dbxref=PMID:24275569,PMID:27619977	
Q9C0E8	UniProtKB	Modified residue	414	414	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TQ95	
Q9C0E8	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20213681,ECO:0000269|PubMed:24223779;Dbxref=PMID:20213681,PMID:24223779	
Q9C0E8	UniProtKB	Alternative sequence	1	123	.	.	.	ID=VSP_020238;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9C0E8	UniProtKB	Alternative sequence	1	9	.	.	.	ID=VSP_020239;Note=In isoform 2. MGGLFSRWR->MEGK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9C0E8	UniProtKB	Alternative sequence	235	235	.	.	.	ID=VSP_054427;Note=In isoform 4. M->MEMGLPHIAQAGLEHLSSSDLSTSTSQSAGIT;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9C0E8	UniProtKB	Natural variant	251	428	.	.	.	ID=VAR_081176;Note=In NEDEHCC. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30032983;Dbxref=PMID:30032983	
Q9C0E8	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Abolishes myristoylation. Inhibits three-way ER tubular junction formation. Does not inhibit transmembrane domain 1-induced membrane translocation. G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24223779,ECO:0000269|PubMed:27619977;Dbxref=PMID:24223779,PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	179	179	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-202%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-211%3B A-213%3B A-218%3B A-227 and A-231. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-213%3B A-218%3B A-227 and A-231. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-213%3B A-218%3B A-227 and A-231. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-218%3B A-227 and A-231. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-218%3B A-227 and A-231. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-227 and A-231. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	218	218	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-227 and A-231. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218 and A-231. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	227	227	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218 and A-231. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	231	231	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis and prevents homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218 and A-227. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	231	231	.	.	.	Note=Inhibits phosphorylation and degradation in mitosis but does not prevent homodimerization and three-way ER tubular junction formations%3B when associated with A-177%3B A-179%3B A-182%3B A-194%3B A-202%3B A-211%3B A-213%3B A-218 and A-227. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27619977;Dbxref=PMID:27619977	
Q9C0E8	UniProtKB	Mutagenesis	276	301	.	.	.	Note=No change in N-myristoylation. Inhibits three-way ER tubular junction formation. CQQCFSHNGMALKEEFEYIAFRCAYC->AQQAFSHNGMALKEEFEYIAFRAAYA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24223779;Dbxref=PMID:24223779	
Q9C0E8	UniProtKB	Sequence conflict	262	262	.	.	.	Note=Y->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9C0E8	UniProtKB	Sequence conflict	374	374	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
